• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[凝血时间延长的混合试验:临床实用性与问题]

[Mixing test for prolonged clotting time: clinical availability and problems].

作者信息

Uchiba Mitsuhiro, Ando Yukio

机构信息

Department of Blood Transfusion and Cell Therapy, Kumamoto University Hospital, Kumamoto 860-8556, Japan.

出版信息

Rinsho Byori. 2009 Oct;57(10):1004-12.

PMID:19928499
Abstract

Prothrombin time (PT) and activated partial thromboplastin time (APTT) are basic laboratory tests for diagnosis of bleeding diseases such as congenital hemophilia. In addition, abnormally prolonged clotting times are observed in patients who have inhibitors. Lupus anticoagulant and inhibitors against coagulation factors are two clinically important inhibitors. However, non-specific inhibitors are also observed. Differential diagnosis of these inhibitors is important. Clotting times are also prolonged by artifactitious factors, such as contamination of heparin. Mixing tests are relatively easy and useful methods which potentially differentiate these abnormalities. This article is summarized the causes of prolongation of clotting times and the usefulness of mixing tests for differentiation of the abnormalities.

摘要

凝血酶原时间(PT)和活化部分凝血活酶时间(APTT)是诊断诸如先天性血友病等出血性疾病的基本实验室检查。此外,在有抑制剂的患者中观察到凝血时间异常延长。狼疮抗凝物和针对凝血因子的抑制剂是两种临床上重要的抑制剂。然而,也观察到非特异性抑制剂。对这些抑制剂进行鉴别诊断很重要。凝血时间也会因人为因素而延长,例如肝素污染。混合试验是相对简单且有用的方法,有可能区分这些异常情况。本文总结了凝血时间延长的原因以及混合试验在鉴别这些异常情况方面的作用。

相似文献

1
[Mixing test for prolonged clotting time: clinical availability and problems].[凝血时间延长的混合试验:临床实用性与问题]
Rinsho Byori. 2009 Oct;57(10):1004-12.
2
Factor VIII inhibitors. Laboratory diagnosis of inhibitors.凝血因子VIII抑制剂。抑制剂的实验室诊断。
Semin Thromb Hemost. 2000;26(2):195-203. doi: 10.1055/s-2000-9823.
3
[Cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome].[用于抗磷脂综合征诊断的检测狼疮抗凝物的交叉混合试验]
Rinsho Byori. 2009 Oct;57(10):990-8.
4
Relevance of clotting tests in liver disease.凝血试验在肝病中的相关性。
Postgrad Med J. 2008 Apr;84(990):177-81. doi: 10.1136/pgmj.2007.066415.
5
Interpreting coagulation assays.解读凝血检测
Blood Coagul Fibrinolysis. 2010 Sep;21 Suppl 1:S3-6. doi: 10.1097/01.mbc.0000388935.77612.d0.
6
Thrombotest mixing experiments in congenital coagulation disorders of the prothrombin complex and in coumarin treated patients. An additional evidence against the presence of an inhibitor in the latter.凝血酶原复合物先天性凝血障碍患者及香豆素治疗患者的凝血酶试验混合实验。这是反对后者存在抑制剂的又一证据。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(3):463-70.
7
[Coagulopathy with autoantibodies to blood-clotting factors: overview and laboratory diagnosis].
Rinsho Byori. 2004 Feb;52(2):178-81.
8
Preoperative history and coagulation screening in children undergoing tonsillectomy.扁桃体切除术患儿的术前病史及凝血筛查
Pediatrics. 1992 Apr;89(4 Pt 2):691-5.
9
Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.急性综合医院中孤立性活化部分凝血活酶时间延长的原因
Singapore Med J. 2005 Sep;46(9):450-6.
10
Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing.获得性凝血障碍:采用全球凝血/抗凝检测方法进行重新评估。
Br J Haematol. 2009 Oct;147(1):77-82. doi: 10.1111/j.1365-2141.2009.07833.x. Epub 2009 Jul 30.